Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antimicrobial defined daily dose in neonatal population.
Villanueva-Bueno C, Montecatine-Alonso E, Jiménez-Parrilla F, Fernández-Llamazares CM, Manrique-Rodríguez S, Zamora-Flores E, Dolz E, Fernández-Polo A, Catillo-Salinas F, Comuñas J, Gallego-Fernández C, González-López M, Gómez-Trevecedo Calvo MT, Gázquez-Pérez R, Álvarez Del Vayo-Benito C, Gil-Navarro MV; Paediatric Antimicrobial Defined Daily Dose Study Group (KiDDDs). Villanueva-Bueno C, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2021 Jun 25:S0213-005X(21)00191-9. doi: 10.1016/j.eimc.2021.05.007. Online ahead of print. Enferm Infecc Microbiol Clin (Engl Ed). 2021. PMID: 34183175 Free article. English, Spanish.
Antimicrobial defined daily dose in neonatal population.
Villanueva-Bueno C, Montecatine-Alonso E, Jiménez-Parrilla F, Fernández-Llamazares CM, Manrique-Rodríguez S, Zamora-Flores E, Dolz E, Fernández-Polo A, Catillo-Salinas F, Comuñas J, Gallego-Fernández C, González-López M, Gómez-Trevecedo Calvo MT, Gázquez-Pérez R, Álvarez Del Vayo-Benito C, Gil-Navarro MV; Paediatric Antimicrobial Defined Daily Dose Study Group (KiDDDs). Villanueva-Bueno C, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2022 Feb;40(2):59-65. doi: 10.1016/j.eimce.2021.05.012. Enferm Infecc Microbiol Clin (Engl Ed). 2022. PMID: 35120651
Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice.
Villanueva-Bueno C, Montecatine-Alonso E, Jiménez-Parrilla F, González-López M, Manrique-Rodríguez S, Moreno-Ramos F, Cañete-Ramírez C, Dolz E, García-Robles A, Caro-Teller JM, Moral-Pumarega MT, Bergon-Sendin E, Gómez-Trevecedo Calvo MT, Gallego-Fernández C, Vayo-Benito CÁD, Mejías-Trueba M, Gil-Navarro MV, Paediatric Antimicrobial Defined Daily Dose Study Group KiDDDs. Villanueva-Bueno C, et al. Antibiotics (Basel). 2023 Mar 17;12(3):602. doi: 10.3390/antibiotics12030602. Antibiotics (Basel). 2023. PMID: 36978469 Free PMC article.
COVID-19 in hospitalised patients in Spain: a cohort study in Madrid.
Rodriguez-Gonzalez CG, Chamorro-de-Vega E, Valerio M, Amor-Garcia MA, Tejerina F, Sancho-Gonzalez M, Narrillos-Moraza A, Gimenez-Manzorro A, Manrique-Rodriguez S, Machado M, Olmedo M, Escudero-Vilaplana V, Villanueva-Bueno C, Torroba-Sanz B, Melgarejo-Ortuño A, Vicente-Valor J, Herranz A, Bouza E, Muñoz P, Sanjurjo M. Rodriguez-Gonzalez CG, et al. Int J Antimicrob Agents. 2021 Feb;57(2):106249. doi: 10.1016/j.ijantimicag.2020.106249. Epub 2020 Nov 28. Int J Antimicrob Agents. 2021. PMID: 33259918 Free PMC article.
Acute pancreatitis in a patient treated with imatinib and gefitinib.
Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Álvarez R, Herranz A, Sanjurjo M. Escudero-Vilaplana V, et al. J Oncol Pharm Pract. 2021 Jun;27(4):980-983. doi: 10.1177/1078155220949639. Epub 2020 Aug 16. J Oncol Pharm Pract. 2021. PMID: 32799779
Potential and real drug interactions in patients treated with abiraterone or enzalutamide in clinical practice.
Vicente-Valor J, Escudero-Vilaplana V, Collado-Borrell R, Pérez-Ramírez S, Villanueva-Bueno C, Narrillos-Moraza Á, García-Sánchez S, Beamud-Cortés M, Herranz A, Sanjurjo M. Vicente-Valor J, et al. Expert Opin Drug Metab Toxicol. 2021 Dec;17(12):1467-1473. doi: 10.1080/17425255.2021.2027908. Epub 2022 Jan 21. Expert Opin Drug Metab Toxicol. 2021. PMID: 35001772
Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale.
Narrillos-Moraza Á, Gómez-Martínez-Sagrera P, Amor-García MÁ, Escudero-Vilaplana V, Collado-Borrell R, Villanueva-Bueno C, Gómez-Centurión I, Herranz-Alonso A, Sanjurjo-Sáez M. Narrillos-Moraza Á, et al. Among authors: villanueva bueno c. JMIR Mhealth Uhealth. 2022 Feb 16;10(2):e32826. doi: 10.2196/32826. JMIR Mhealth Uhealth. 2022. PMID: 35171109 Free PMC article. Review.
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents.
Escudero-Vilaplana V, Collado-Borrell R, Gómez Martínez-Sagrera P, Villanueva-Bueno C, Revuelta-Herrero JL, Gonzalez-Haba E, Hoyo-Muñoz Á, Jerez Gilarranz Y, Marzal-Alfaro B, Herranz A, Martin M, Sanjurjo M. Escudero-Vilaplana V, et al. Among authors: villanueva bueno c. J Cancer Res Clin Oncol. 2023 Jul;149(7):2855-2882. doi: 10.1007/s00432-022-04172-1. Epub 2022 Jul 6. J Cancer Res Clin Oncol. 2023. PMID: 35790560
19 results